Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT)’s traded shares stood at 0.44 million during the last session. At the close of trading, the stock’s price was $3.82, to imply an increase of 4.66% or $0.17 in intraday trading. The CRXT share’s 52-week high remains $31.24, putting it -717.8% down since that peak but still an impressive 10.21% since price per share fell to its 52-week low of $3.43. The company has a valuation of $102.87M, with an average of 0.72 million shares in intraday trading volume over the past 10 days and average of 1.03 million shares over the past 3 months.
Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) trade information
After registering a 4.66% upside in the last session, Clarus Therapeutics Holdings Inc. (CRXT) has traded red over the past five days. The stock hit a weekly high of 4.30 this Friday, 10/08/21, jumping 4.66% in its intraday price action. The 5-day price performance for the stock is -11.16%, and -60.33% over 30 days. With these gigs, the year-to-date price performance is -62.48%. Short interest in Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) saw shorts transact 21230.0 shares and set a 0.02 days time to cover.
Analysts on Wall Street suggest a consensus price target of $14.25, implying an increase of 73.19% to the stock’s current value. The extremes give us $12.00 and $20.00 for target low and target high price respectively. As such, CRXT has been trading -423.56% off suggested target high and -214.14% from its likely low.
Clarus Therapeutics Holdings Inc. (CRXT) estimates and forecasts
Clarus Therapeutics Holdings Inc. has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Clarus Therapeutics Holdings Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT)’s Major holders
Clarus Therapeutics Holdings Inc. insiders hold 1.38% of total outstanding shares, with institutional holders owning 105.29% of the shares at 106.76% float percentage. In total, 105.29% institutions holds shares in the company.